King Wealth Abb Vie Inc. Transaction History

King Wealth

$642 Million
Q3 2024

A detailed history of King Wealth transactions in Abb Vie Inc. stock. As of the latest transaction made, King Wealth holds 7,618 shares of ABBV stock, worth $1.37 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

7,618

Previous 7,769 1.94%

Holding current value

$1.37 Million

Previous $1.33 Million 12.91%

% of portfolio

0.23%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $24,739 - $30,098	-151 Reduced 1.94%	7,618 $1.5 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $13,157 - $15,364	85 Added 1.11%	7,769 $1.33 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $2,716 - $3,095	-17 Reduced 0.22%	7,684 $1.4 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $693,228 - $780,738	5,038 Added 189.19%	7,701 $1.19 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $34,466 - $39,899	-258 Reduced 8.83%	2,663 $397,000
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $5,167 - $6,431	39 Added 1.35%	2,921 $394,000
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $433 - $499	3 Added 0.1%	2,882 $459,000
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $25,449 - $30,520	184 Added 6.83%	2,879 $465,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $30,197 - $34,634	225 Added 9.11%	2,695 $362,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $275 - $349	2 Added 0.08%	2,470 $378,000
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $317,939 - $394,473	-2,409 Reduced 49.4%	2,468 $400,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $50,062 - $63,343	-466 Reduced 8.72%	4,877 $660,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $425 - $483	4 Added 0.07%	5,343 $576,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $31,562 - $35,163	300 Added 5.95%	5,339 $601,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $14,526 - $15,992	-142 Reduced 2.74%	5,039 $545,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $25,595 - $34,557	-318 Reduced 5.78%	5,181 $555,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $214,345 - $251,570	2,495 Added 83.06%	5,499 $482,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $220,403 - $294,932	3,004 New	3,004 $295,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $3.22 Million - $3.58 Million	-36,226 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $125,153 - $148,084	1,394 Added 4.0%	36,226 $3.36 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $155,036 - $207,608	1,685 Added 5.08%	34,832 $3.3 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $54,721 - $60,006	611 Added 1.88%	33,147 $3.21 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $996,689 - $1.27 Million	-14,269 Reduced 30.49%	32,536 $2.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,805	46,805 $3.39 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account